Form 4: Charles River Labs Executive Reports Stock Transfer
Statement of Changes in Beneficial Ownership
Shannon M. Parisotto, CEVP of Charles River Laboratories, reported a transfer of shares to a revocable trust and tax-related dispositions.
Summary
- Shannon M. Parisotto, CEVP of Discovery & Safety Assessment, transferred 7,169 shares of common stock to a revocable trust on February 6, 2026.
- The reporting person disposed of 168 shares on May 26, 2026, at $160.30 per share to cover tax obligations.
- The reporting person disposed of 105 shares on May 27, 2026, at $156.73 per share to cover tax obligations.
- Following these transactions, the reporting person holds 7,742 shares directly and 8,151 shares indirectly via trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transactions are administrative in nature and do not reflect a change in the executive's long-term outlook.
Positives
- The primary transaction was an internal transfer to a revocable trust, maintaining the reporting person's overall economic interest in the company.
Negatives
- The reporting person sold a total of 273 shares to satisfy tax withholding obligations related to equity vesting.
Risks
- None identified; this is a routine disclosure of executive equity movements.
Future Outlook
No forward-looking guidance provided in this filing.
Industry Context
StockSavvy.ai notes that routine Form 4 filings regarding tax withholding and trust transfers are standard corporate governance practices and do not typically signal changes in executive sentiment regarding company performance.
Comparison to Industry Standards
- The filing follows standard SEC reporting requirements for executive officers under Section 16(a).
- The use of 'sell-to-cover' transactions for tax obligations is a common practice among executives at large-cap firms like Charles River Laboratories.
Stakeholder Impact
- No material impact on shareholders or company operations.
Next Steps
- None
Key Dates
| Date | Description |
|---|---|
| 02/06/2026 | Date of share transfer to trust and initial reporting transaction. |
| 05/26/2026 | Disposition of shares for tax withholding. |
| 05/27/2026 | Disposition of shares for tax withholding and filing date. |
Keywords
Charles River Laboratories, CRL, Insider Trading, Form 4, Equity Ownership, Shannon Parisotto
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.